Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MAPT | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | PREPL | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | GNB1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | SH2B3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | CTD-3105H18.18 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | LHFP | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | NOVA1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | COL9A3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | NFE2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | RSBN1L | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |